GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Research & Development

LSL Pharma Group (TSXV:LSL) Research & Development : C$-0.06 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. LSL Pharma Group's Research & Development for the three months ended in Jun. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.06 Mil.

LSL Pharma Group Research & Development Historical Data

The historical data trend for LSL Pharma Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Research & Development Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Research & Development
- - 0.67 0.07

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.01 -0.08 - -

LSL Pharma Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LSL Pharma Group  (TSXV:LSL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

LSL Pharma Group Research & Development Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Research & Development
Comparable Companies
XCNQ:ACRG.A.U TSX:AVNT XCNQ:MMEN XCNQ:CXXI TSX:AVCN XCNQ:TIUM.U TSXV:CANB XCNQ:GDNS TSXV:PCLO TSX:LABS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines